Global Emergency Contraceptive Pills Market Overview

Global Emergency Contraceptive Pills Market was valued at USD 1.00 billion in 2021 and is expected to reach USD 1.14 billion by the year 2028, at a CAGR of 1.8%.

Emergency contraception may be a method of preventing pregnancy following unprotected sex. Emergency contraceptive pills (ECPs), also referred to as the contraceptive, are pills that must be taken before 120 hours (5 days) after having unprotected sex. The prescription Preven Emergency Contraception Kit was developed in the late 1990s. it had been modeled after the Yuzpe method and included four combination pills, alongside instructions and a urine bioassay. Some sorts of emergency contraception are best when used within 72 hours (3 days) of intercourse. The emergency pill works by postponing ovulation (the release of an egg during the monthly cycle). ECPs won't terminate a pregnancy if fertilization and implantation have already occurred.

Some sorts of emergency contraceptive pills are available without a prescription at drug stores and pharmacies for people of all ages. One sort of emergency contraception (which works well for up to five days after unprotected sex) can only be obtained with a prescription. To avoid unwanted pregnancy, any woman or girl of reproductive age may require emergency contraception. There are not any absolute medical reasons to avoid using emergency contraception. There are no age limits for using emergency contraception. Furthermore, the rising number of unintended pregnancies among women aged 15 to 44 is expected to fuel the growth of the emergency contraceptive pill market over the forecast period.

Market Dynamics And Factors For Emergency Contraceptive Pills Market

Drivers:

Increase In The Number Of Unplanned Pregnancies

Nearly 5% of reproductive-age women have an unintended pregnancy annually. The unintended pregnancy rate is significantly higher within the USA than in many other developed countries. Emergency contraception pills prevent unintended pregnancy by preventing or delaying ovulation and do not induce abortion. The copper-containing IUD prevents fertilization by inducing a chemical reaction in the sperm and egg before they meet. Emergency contraception (EC) may be a safe and effective way to prevent an unwanted pregnancy following unprotected sexual activity. Many unwanted pregnancies end in unsafe abortions. Thus, even when not planning for a pregnancy, exposure to unprotected sex takes place often, necessitating the utilization of emergency contraception. Hence, owing to the growing number of unplanned pregnancies, the studied market is expected to propel over the forecast period.

 Restraints:

 Side-Effects Related To The Emergency Contraceptive Pills

 The emergency Contraceptive pill, sometimes called the contraceptive, has been found to possess any long-term or serious side effects. However, some sorts of emergency contraceptive pills cause minor side effects which may be liable for hindering the market of emergency contraceptive pills. The more common side effects of ECPs include spotting for a couple of days after use and an irregular period for a subsequent month or two. Some women may have nausea and vomiting after taking ECPs. There's no teratogenic risk that has been found with pregnancies that occur while women are taking high-dose contraception pills, it's unlikely that there's an increased risk of birth defects in babies born to adolescent girls who have taken emergency contraception during pregnancy is expected to hinder the growth of the emergency contraceptive market.

Opportunities:

The Rising Adoption Rate Of Emergency Contraceptive Pills

The high rate of urbanization, especially in several developing nations is one of the main factors that are likely to accelerate the expansion of the worldwide market within the next few years. The rising income of consumers and therefore the rising adoption rate of emergency contraceptive pills are likely to encourage the expansion of the market throughout the forecast period. The rising awareness among people is one of the key factors that's projected to accelerate the expansion of the worldwide emergency contraceptive pills market within the next few years. The enhancement of the distribution network with the straightforward availability of those pills is probably going to reinforce the expansion of the market within the next few years. The leading players within the market are emphasizing the event of the latest products and therefore the easy availability for people, which is projected to support the expansion of the general market throughout the forecast period.

Segmentation Analysis Of Emergency Contraceptive Pills Market

By product type, the combination pill segment is forecasted to dominate the emergency contraceptive pill market in the upcoming future. The combined pill is an oral contraceptive that contains a combination of synthetic hormones. These chemicals closely resemble the naturally produced female hormones, estrogen, and progesterone, which help regulate ovulation i.e. the formation and release of the egg. Combination pills see relatively higher sales in the global market, owing to their health benefits in lowering the risk of ectopic pregnancy. Combination pills lessen the pain of menstrual cramps, keep acne under control, and protect against certain cancers. As with all medications, they do have some potential risks and side effects. These include an increased risk of blood clots and a small increase in breast cancer risk. Thus, the contraceptive pill segment is expected to grow significantly during the forecast period due to the aforementioned factors.

By Distribution Channel, the offline segment is predicted to have a lion's share in the emergency contraceptive pills market. Emergency Contraceptive Pills Market has been segmented into Online and Offline. Drug stores and hospital pharmacies come under offline application of emergency contraceptive pills and are the two largest sales channels for emergency contraceptive pills. Sales of emergency contraceptive pills through these channels are expected to be more as compared to online sales of emergency contraceptive pills. The Medicines and Healthcare products Regulatory Agency (MHRA) has approved two brands of progestogen-only contraceptive pills, containing desogestrel, to buy in community pharmacies without a prescription. Thus, driving the growth of the offline segment.

Regional Analysis Of Emergency Contraceptive Pills Market

The North American region is anticipated to dominate the contraceptive pills market in the analysis period. A US-based organization, that is focusing on expanding proper access to emergency contraceptive products. In the US region, among all sexually active women, not seeking pregnancy, 93% of unmarried women who lived with a partner used contraceptives, which is likely to support the growth of this region in the coming few years.

 The Asia Pacific region is anticipated to have the second-highest share of the emergency contraceptive pills market over the forecast period. The Asia Pacific is developing urban culture among the developing economies and the rising awareness among people is projected to encourage the growth of the emergency contraceptive pills market across the Asia Pacific in the next few years.

The emergency contraceptive pills market in the Europe region is expected to develop at a significant growth rate in the analysis period. Europe showcases the rise in mutual consent of partners towards unprotected sex. Although unprotected coitus fuels the risks of sexually transmitted infections, emergency contraceptive pills are unable to offer protection against venereal diseases, which further negates their status in terms of adoption. The growing adoption rate of emergency contraceptive pills is fueling the growth of the emergency contraceptive pills market in the forecast period.

The emergency contraceptive pills market in the Middle East and Africa region is expected to develop at a significant growth in the projected timeframe. The rising awareness among people is projected to encourage the growth of the emergency contraceptive pills market across the MEA region.

Covid-19 Impact Analysis On The Emergency Contraceptive Pills Market

 The Coronavirus disease pandemic has disrupted reproductive health services including a decline in the use of pre-coital contraceptives. ECS are preferred as convenient post-coital methods and evidence from elsewhere shows that infectious disease outbreaks including COVID-19 impact negatively the use of specific contraceptive methods. Emergency contraceptive use before the pandemic, increasing users per. However, the pandemic caused a sudden spike in the use of emergency contraceptives. The pandemic and its related restrictions had an instantaneous effect on the utilization of emergency contraceptives. The disruption of face-to-face contraceptive consultations in General Practice during a COVID-19 ‘lockdown’ has resulted in a reduction in estrogen-containing methods compared to progestogen-only methods, which require less face-to-face monitoring.

Top Key Players Covered In Emergency Contraceptive Pills Market

• Teva Pharmaceutical Industries Ltd. (Israel)
• Bayer AG (Germany)
• HRA Pharma (France)
• Piramal Enterprises Limited (India)
• Mankind Pharma Ltd. (India)
• Richter Gedeon Nyrt (Hungary)
• Lupin Limited (India)
• Cooper Pharma (India)
• Pfizer Inc. (US)
• Zhejiang Xianju Pharmaceutical Co. (China) and Other Major Players.

Key Industry Development In The Emergency Contraceptive Pills Market

 In March 2022, FDA urged to allow emergency contraceptive pills. An advocacy group for family planning has urged the Food and Drug Administration (FDA) to reconsider lifting the 20-year-old ban on emergency contraceptive (EC) pills as the country resumes face-to-face operations in the face of declining Covid-19 cases.

In March 2022, A contraceptive or Morning After pill. A male pill found to be 99 percent effective in mice is predicted to enter human trials by the top of this year. The findings are going to be presented at the American Chemical Society's spring meeting, and mark a key step towards expanding contraception options also as responsibilities for men.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product Type
 3.2 By Distribution Channel

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Emergency Contraceptive Pills Market by Product Type
 5.1 Emergency Contraceptive Pills Market Overview Snapshot and Growth Engine
 5.2 Emergency Contraceptive Pills Market Overview
 5.3 Progesterone Pills
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Progesterone Pills: Grographic Segmentation
 5.4 Estrogen Pills
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Estrogen Pills: Grographic Segmentation
 5.5 Combination Pills
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Combination Pills: Grographic Segmentation
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Grographic Segmentation

Chapter 6: Emergency Contraceptive Pills Market by Distribution Channel
 6.1 Emergency Contraceptive Pills Market Overview Snapshot and Growth Engine
 6.2 Emergency Contraceptive Pills Market Overview
 6.3 Online
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Online: Grographic Segmentation
 6.4 Offline
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Offline: Grographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Emergency Contraceptive Pills Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Ansoff Matrix
  7.1.5 Emergency Contraceptive Pills Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Emergency Contraceptive Pills Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 TEVA PHARMACEUTICAL INDUSTRIES LTD.
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 BAYER AG
 7.4 HRA PHARMA
 7.5 PIRAMAL ENTERPRISES LIMITED
 7.6 MANKIND PHARMA LTD.
 7.7 RICHTER GEDEON NYRT
 7.8 LUPIN LIMITED
 7.9 COOPER PHARMA
 7.10 PFIZER INC.
 7.11 ZHEJIANG XIANJU PHARMACEUTICAL CO.
 7.12 OTHER MAJOR PLAYERS

Chapter 8: Global Emergency Contraceptive Pills Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Product Type
  8.2.1 Progesterone Pills
  8.2.2 Estrogen Pills
  8.2.3 Combination Pills
  8.2.4 Others
 8.3 Historic and Forecasted Market Size By Distribution Channel
  8.3.1 Online
  8.3.2 Offline

Chapter 9: North America Emergency Contraceptive Pills Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Product Type
  9.4.1 Progesterone Pills
  9.4.2 Estrogen Pills
  9.4.3 Combination Pills
  9.4.4 Others
 9.5 Historic and Forecasted Market Size By Distribution Channel
  9.5.1 Online
  9.5.2 Offline
 9.6 Historic and Forecast Market Size by Country
  9.6.1 U.S.
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Europe Emergency Contraceptive Pills Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Product Type
  10.4.1 Progesterone Pills
  10.4.2 Estrogen Pills
  10.4.3 Combination Pills
  10.4.4 Others
 10.5 Historic and Forecasted Market Size By Distribution Channel
  10.5.1 Online
  10.5.2 Offline
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Germany
  10.6.2 U.K.
  10.6.3 France
  10.6.4 Italy
  10.6.5 Russia
  10.6.6 Spain
  10.6.7 Rest of Europe

Chapter 11: Asia-Pacific Emergency Contraceptive Pills Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product Type
  11.4.1 Progesterone Pills
  11.4.2 Estrogen Pills
  11.4.3 Combination Pills
  11.4.4 Others
 11.5 Historic and Forecasted Market Size By Distribution Channel
  11.5.1 Online
  11.5.2 Offline
 11.6 Historic and Forecast Market Size by Country
  11.6.1 China
  11.6.2 India
  11.6.3 Japan
  11.6.4 Singapore
  11.6.5 Australia
  11.6.6 New Zealand
  11.6.7 Rest of APAC

Chapter 12: Middle East & Africa Emergency Contraceptive Pills Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product Type
  12.4.1 Progesterone Pills
  12.4.2 Estrogen Pills
  12.4.3 Combination Pills
  12.4.4 Others
 12.5 Historic and Forecasted Market Size By Distribution Channel
  12.5.1 Online
  12.5.2 Offline
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Turkey
  12.6.2 Saudi Arabia
  12.6.3 Iran
  12.6.4 UAE
  12.6.5 Africa
  12.6.6 Rest of MEA

Chapter 13: South America Emergency Contraceptive Pills Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product Type
  13.4.1 Progesterone Pills
  13.4.2 Estrogen Pills
  13.4.3 Combination Pills
  13.4.4 Others
 13.5 Historic and Forecasted Market Size By Distribution Channel
  13.5.1 Online
  13.5.2 Offline
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Brazil
  13.6.2 Argentina
  13.6.3 Rest of SA

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. EMERGENCY CONTRACEPTIVE PILLS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. EMERGENCY CONTRACEPTIVE PILLS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. EMERGENCY CONTRACEPTIVE PILLS MARKET COMPETITIVE RIVALRY
TABLE 005. EMERGENCY CONTRACEPTIVE PILLS MARKET THREAT OF NEW ENTRANTS
TABLE 006. EMERGENCY CONTRACEPTIVE PILLS MARKET THREAT OF SUBSTITUTES
TABLE 007. EMERGENCY CONTRACEPTIVE PILLS MARKET BY PRODUCT TYPE
TABLE 008. PROGESTERONE PILLS MARKET OVERVIEW (2016-2028)
TABLE 009. ESTROGEN PILLS MARKET OVERVIEW (2016-2028)
TABLE 010. COMBINATION PILLS MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. EMERGENCY CONTRACEPTIVE PILLS MARKET BY DISTRIBUTION CHANNEL
TABLE 013. ONLINE MARKET OVERVIEW (2016-2028)
TABLE 014. OFFLINE MARKET OVERVIEW (2016-2028)
TABLE 015. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 016. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 017. N EMERGENCY CONTRACEPTIVE PILLS MARKET, BY COUNTRY (2016-2028)
TABLE 018. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 019. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 020. EMERGENCY CONTRACEPTIVE PILLS MARKET, BY COUNTRY (2016-2028)
TABLE 021. ASIA PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 022. ASIA PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 023. EMERGENCY CONTRACEPTIVE PILLS MARKET, BY COUNTRY (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 026. EMERGENCY CONTRACEPTIVE PILLS MARKET, BY COUNTRY (2016-2028)
TABLE 027. SOUTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 028. SOUTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 029. EMERGENCY CONTRACEPTIVE PILLS MARKET, BY COUNTRY (2016-2028)
TABLE 030. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SNAPSHOT
TABLE 031. TEVA PHARMACEUTICAL INDUSTRIES LTD.: BUSINESS PERFORMANCE
TABLE 032. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 033. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 033. BAYER AG: SNAPSHOT
TABLE 034. BAYER AG: BUSINESS PERFORMANCE
TABLE 035. BAYER AG: PRODUCT PORTFOLIO
TABLE 036. BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. HRA PHARMA: SNAPSHOT
TABLE 037. HRA PHARMA: BUSINESS PERFORMANCE
TABLE 038. HRA PHARMA: PRODUCT PORTFOLIO
TABLE 039. HRA PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. PIRAMAL ENTERPRISES LIMITED: SNAPSHOT
TABLE 040. PIRAMAL ENTERPRISES LIMITED: BUSINESS PERFORMANCE
TABLE 041. PIRAMAL ENTERPRISES LIMITED: PRODUCT PORTFOLIO
TABLE 042. PIRAMAL ENTERPRISES LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. MANKIND PHARMA LTD.: SNAPSHOT
TABLE 043. MANKIND PHARMA LTD.: BUSINESS PERFORMANCE
TABLE 044. MANKIND PHARMA LTD.: PRODUCT PORTFOLIO
TABLE 045. MANKIND PHARMA LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. RICHTER GEDEON NYRT: SNAPSHOT
TABLE 046. RICHTER GEDEON NYRT: BUSINESS PERFORMANCE
TABLE 047. RICHTER GEDEON NYRT: PRODUCT PORTFOLIO
TABLE 048. RICHTER GEDEON NYRT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. LUPIN LIMITED: SNAPSHOT
TABLE 049. LUPIN LIMITED: BUSINESS PERFORMANCE
TABLE 050. LUPIN LIMITED: PRODUCT PORTFOLIO
TABLE 051. LUPIN LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. COOPER PHARMA: SNAPSHOT
TABLE 052. COOPER PHARMA: BUSINESS PERFORMANCE
TABLE 053. COOPER PHARMA: PRODUCT PORTFOLIO
TABLE 054. COOPER PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. PFIZER INC.: SNAPSHOT
TABLE 055. PFIZER INC.: BUSINESS PERFORMANCE
TABLE 056. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 057. PFIZER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. ZHEJIANG XIANJU PHARMACEUTICAL CO.: SNAPSHOT
TABLE 058. ZHEJIANG XIANJU PHARMACEUTICAL CO.: BUSINESS PERFORMANCE
TABLE 059. ZHEJIANG XIANJU PHARMACEUTICAL CO.: PRODUCT PORTFOLIO
TABLE 060. ZHEJIANG XIANJU PHARMACEUTICAL CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 061. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 062. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 063. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. PROGESTERONE PILLS MARKET OVERVIEW (2016-2028)
FIGURE 013. ESTROGEN PILLS MARKET OVERVIEW (2016-2028)
FIGURE 014. COMBINATION PILLS MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY DISTRIBUTION CHANNEL
FIGURE 017. ONLINE MARKET OVERVIEW (2016-2028)
FIGURE 018. OFFLINE MARKET OVERVIEW (2016-2028)
FIGURE 019. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. ASIA PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. SOUTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY COUNTRY (2016-2028)